ABCA1, ATP-binding cassette transporter A1; ABCG1, ATP-binding cassette transporter G1; apoA-I, apolipoprotein A-I; BHK, Baby hamster kidney cell; CE, cholesteryl ester; CHO, Chinese Hamster Ovary cell; GGE, gradient gel electrophoresis; HDL, high density lipoprotein; LXRα, liver X receptor α; LXRβ, liver X receptor β; RCT, reverse cholesterol transport; RXR, retinoid X receptor; SR-BI, class B scavenger receptor type 1; WT, wild-type ABCG1-deficient cells showed similar capacity to efflux cholesterol to apoA-I and to form nascent HDL particles compared to WT cells. Cholesterol efflux to apoA-I and nascent HDL formation were slightly but significantly enhanced in SR-BI-deficient cells compared with WT cells under basal but not LXR activated conditions. As in WT but not in ABCA1-deficient hepatocytes, 7.2 nm-sized particles generated by glyburide treatment were also detected in ABCG1-deficient and SR-BI-deficient hepatocytes. Our data indicate that hepatic nascent HDL formation is highly dependent on ABCA1, but not on ABCG1 or SR-BI.
Introduction
High-density lipoprotein (HDL) constitutes a heterogeneous group of particles differing in density, size, electrophoretic mobility, lipid composition and apolipoprotein content.
Numerous epidemiological studies indicate that HDL particles serve an anti-atherogenic function in that high levels of HDL cholesterol are associated with a decreased risk of atherosclerosis (1) . An important atheroprotective effect of HDL is its ability to remove excess cholesterol from peripheral tissues and deliver it to the liver for biliary excretion, by a process called reverse cholesterol transport (RCT) (2) (3) (4) . Beyond promotion of RCT, other properties of HDL, including anti-inflammatory, anti-oxidative, antithrombotic and anti-apoptotic features of HDL, also contribute to its anti-atherogenic function (5) . However, the fundamental mechanisms underlying the biogenesis and maintenance of plasma HDL levels are not well understood.
ATP binding cassette transporter A1 (ABCA1) is recognized as the principal molecule involved in cholesterol efflux from macrophage foam cells (6) . It is expressed in a variety of cell types, including hepatocytes and macrophages and is highly up-regulated upon lipid loading through the activation of the nuclear liver X receptors (LXRα and/or LXRβ) (7, 8) . The absence of functional ABCA1 in Tangier disease patients results in severe HDL deficiency and deposition of cholesteryl esters (CE) in the reticulo-endothelial system (9) (10) (11) . HDL deficiency and macrophage foam cell accumulation are also found in mice lacking ABCA1 in the liver (12) . The observed HDL deficiency is a direct result of a severely impaired lipidation of apoA-I via the ABCA1 pathway; therefore, this pathway by guest, on www.jlr.org
Downloaded from
is not only important for lipid efflux from both peripheral and hepatic cells, but also for the biogenesis of nascent HDL and maintenance of plasma HDL levels (13). The generation of nascent apoA-I-containing particles has been studied in various cell lines.
Incubation of exogenous apoA-I with fibroblasts, CaCo-2, or CHO-overexpressing ABCA1 cells generated a series of α-migrating apoA-I containing particles with diameters of 8-20 nm. The generation of such nascent HDL particles is dependent on ABCA1 since cells lacking ABCA1 or expressing an inactive ABCA1 mutant (Q597R) were unable to form such particles. (14) (15) (16) (17) . Interestingly, incubation of exogenous apoA-I with either HepG2 or macrophages generated not only α-migrating but also preβ 1 -migrating particles, suggesting the presence of a link between specific cell types and the speciation of nascent HDL particles (15) . The formation of nascent HDL particles has also been studied in primary hepatocytes. Analyzing culture medium of hepatocytes from ABCA1-deficient mice demonstrated a lack of nascent HDL production (16) or markedly reduced production of qualitatively similar particles (18) . The mechanisms of the formation of nascent HDL particles in hepatocytes remain unclear.
In addition to ABCA1, another ABC transporter ABCG1 has been shown to contribute to cholesterol efflux from macrophages (19). Newly formed nascent HDL particles generated through ABCA1 action were shown to function as efficient acceptors for ABCG1-mediated cholesterol efflux. A synergistic relationship between ABCA1 and ABCG1 in promoting cholesterol efflux has been proposed (20, 21) . The role of ABCG1 in regulating HDL levels is uncertain. In chow fed animals, ABCG1 did not influence HDL levels, possibly due to its low level of expression under these conditions (22) . In by guest, on www.jlr.org Downloaded from 6 contrast, ABCG1-deficient mice were shown to exhibit decreased plasma HDL cholesterol levels when fed a high cholesterol diet (22) . Other studies, however, failed to show altered HDL levels in ABCG1 deficient mice even when fed a high fat diet, or in ABCG1 transgenic mice (23) (24) (25) . These studies did provide evidence for a role of hepatic ABCG1 in regulating both biliary cholesterol secretion (22) and lipid accumulation (24) .
However, the role of ABCG1 in the process of hepatic HDL formation has not been examined.
Class B Scavenger Receptor Type 1 (SR-BI) is recognized primarily as an HDL receptor.
SR-BI is abundantly expressed in the liver where it functions to deliver HDL CE into liver for cholesterol secretion (26) . SR-BI can also promote cellular cholesterol efflux to HDL (27) . However, SR-BI has been reported to inhibit ABCA1-mediated cholesterol efflux in macrophage possibly through its ability to mediate cellular cholesterol uptake (28) . The possible effects of SR-BI on HDL biogenesis have not been studied. In this study, we investigated the roles of these cholesterol transporters in cholesterol efflux and nascent HDL biogenesis in primary hepatocytes.
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Materials and methods
Animals and Cells
Liver-specific ABCA1-knockout mice (albumin Cre Baby hamster kidney (BHK) cells expressing human ABCA1 or human N-terminal FLAG-tagged ABCG1 were generous gift from J. F. Oram (30, 31) . They were generated using the mifepristone-inducible GeneSwitch system. Cells were grown in DMEM supplemented with 10% FBS, 1% penicillin and streptomycin, as well as 2 mM glutamine. ABCA1 and ABCG1 were induced with overnight incubation of cells with DMEM containing 0.2% fatty acid-free BSA and 10 nM mifepristone (Invitrogen). All cell culture incubations were performed at 37ºC in a humidified 5% CO 2 incubator.
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Preparation of human HDL 3 and rHDL HDL (d = 1.063-1.21 g/ml) was isolated from human plasma by density gradient ultracentrifugation. Human HDL was subfractionated to obtain HDL 3 (d = 1.13 -1.18 g/ml) as described (32). Reconstituted HDL (rHDL) was prepared by the sodium cholate dialysis method as described (33). Briefly, rHDL containing human apoA-I was prepared using molar ratios of 1/5/95, apoA-I/free cholesterol/palmitoyloleoylphosphatidylcholine (POPC). The purity and size of rHDL were examined on 4-20% non-denaturing gradient gel electrophoresis (GGE). The rHDL particles were ~100 Å in diameter and particles were >95% homogeneous in size.
Primary hepatocyte preparation
The procedure for isolation of mouse primary hepatocytes was based on Seglen's twostep perfusion method (34). Briefly, liver was perfused through the portal vein with Ca 2+ /Mg 2+ -free Hanks' Balanced Salt Solution containing 10 mM glucose, 10 mM HEPES and 0.3 mM EDTA followed by Hanks' Balanced Salt Solution containing 0.05% collagenase type IV (Sigma C5138). The cell suspension was spun down at 50 x g for 2 min. After three washes, hepatocytes were resuspended in Williams' Medium E (GIBCO) containing 10% fetal bovine serum (GIBCO), 2% penicillin-streptomycin, 1% sodium pyruvate, 1% L-glutamine and 1% insulin-transferrin-selenium (GIBCO). In line with previous reports (35, 36), hepatocytes comprised 98% (98% ± 0.3 in six preparations) of the isolated cells as judged by cell morphology and size. Cell viability assessed by trypan blue exclusion was 94% ± 0.7 from six preparations. Hepatocytes were plated into 12-well plates (2 x 10 5 cells/per well) pre-coated with rat tail collagen (BD Biosciences) and 9 incubated at 37°C in 5% CO 2 . After overnight cell culture, the LXR agonist T0901317
(Cayman) was used to stimulate ABCA1 and ABCG1 transporter expression.
Real time PCR
Total RNA was isolated from primary hepatocytes using TRIzol Reagent (Invitrogen)
according to the manufacturer's protocol. RNA samples were treated with DNase I (Roche) for 30 min at 37ºC and then purified with the RNeasy Mini Kit (QIAGEN). RNA (2 µg) was reverse transcribed into cDNA using a reverse transcription system (Promega). After 4-fold dilution, 5 µl was used as a template for real-time PCR.
Amplification was done for 40 cycles using Power SYBR Green PCR master Mix Kit (Applied Biosystems). Quantification was performed using the standard curve method and normalizing to GAPDH. The primers used for ABCG1 are as follows: mABCG1, NM_009593: forward 5'-aggtctcagccttctaaagttcctc-3', reverse 5'-tctctcgaagtgaatgaaatttatcg-3', 85bp. in medium containing 0.2% fatty acid-free BSA during the 16 h equilibration period.
Western blotting
Cells were then pretreated in the presence or absence of glyburide (500 µM) in serumfree medium containing 0.2% fatty acid-free BSA for 1 h at 37°C and then incubated with the same concentration of glyburide in the presence or absence of 20 µg/ml lipidfree human apoA-I (Biodesign, Meridian Life Science, Saco, ME) for the indicated time period. Following incubation, radioactivity in the medium and cells was determined.
Efflux was calculated as the percentage of counts in the medium relative to the total counts in the medium and cells together. Values shown were the mean ± SEM of triplicate determinations.
Nascent HDL particle formation
ApoA-I lipidation and nascent HDL particle formation was determined in the same cell culture experiments used to determine cholesterol efflux. 
Chemical cross-linking and immunoprecipitation analysis
Chemical cross-linking and immunoprecipitation analysis was performed essentially as previously described (38) with the following modifications. Hepatocytes were plated into 
Statistical analysis
Statistics were calculated with Graphpad's Prism software. Data were expressed as means ± SEM. Results were analyzed by two-way ANOVA with a Bonferroni post-test.
Significance was set at *: P < 0.05; **: P < 0.01; ***: P < 0.001.
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Results
Role of ABCA1 in cholesterol efflux and nascent HDL formation in primary hepatocytes
To investigate the role of ABCA1 in nascent HDL formation in hepatocytes we examined cultures of primary mouse hepatocytes. The known LXR agonist, T0901317, was used to stimulate the expression of the ABCA1 and ABCG1 transporters (39) and the lipidation of exogenously added apoA-I was then analyzed by non-denaturing gel electrophoresis.
As expected, ABCA1 expression was markedly up-regulated by T0901317 and high expression levels were maintained during the incubation period (Fig. 1B) . As shown in Figure 1A , incubation of cells with lipid-free apoA-I resulted in the formation of a series of discretely sized nascent HDL particles whose generation was markedly increased by T0901317. The nascent HDLs produced were similar in size to those produced by other cells, including macrophages and hepatocytes (15) . The formation of small as well as large nascent HDL particles increased with time. However, it is not clear whether the smaller particles serve as precursors of larger particles.
To investigate the specific role of ABCA1 in both cholesterol efflux and nascent HDL formation, primary hepatocytes from liver-specific ABCA1 knockout mice and C57BL/6 control mice were used. Cells were pretreated with T0901317 for 16 h and then incubated with apoA-I (20 µg/ml) for 16 h in the presence or absence of glyburide, an inhibitor of ABCA1 transporter activity (15, 40) . Following the incubation, ABCA1 protein expression in ABCA1+/+ hepatocytes was markedly increased by LXR activation ( Cholesterol efflux to apoA-I was very low in hepatocytes from ABCA1-/-mice, both under normal and LXR stimulated conditions (Fig. 2B ).
In line with cholesterol efflux to apoA-I, apoA-I lipidation was similarly increased to a marked degree by LXR activation in ABCA1+/+ hepatocytes, as evident from the formation of the major nascent HDL species having sizes of 7.4, 9.2, and 10.6 nm diameter (Fig. 2C) . In contrast to ABCA1+/+ hepatocytes, no apoA-I lipidation was detected in ABCA1-/-hepatocytes, indicating that nascent HDL formation required ABCA1. As expected, glyburide treatment abolished the formation of the major nascent HDLs in ABCA1+/+ hepatocytes. Interestingly, treatment with this ABCA1 inhibitor led to the formation of a novel distinct 7.2 nm diameter species, which was generated by ABCA1+/+ hepatocytes under both LXR activated and non-activated conditions. As in the case of nascent HDLs, LXR activation markedly increased the formation of the 7.2 nm particles in ABCA1+/+ cells. The accumulation of the 7.2 nm particles in the presence of glyburide suggested that their formation resulted from the lipidation of apoA-I that was independent of ABCA1 transporter activity. Unexpectedly, however, no 7.2 nm particles were detected in ABCA1-/-hepatocytes ( Fig. 2C) , indicating that the formation 15 of these particles required ABCA1 expression. This was in line with the observed increase in 7.2 nm particles in the case of ABCA1+/+ hepatocytes treated with T0901317 compared with that in basal conditions. Overall, the extent of cholesterol efflux to apoA-I was correlated with the levels of apoA-I lipidation in this experiment.
The mechanism by which glyburide affects the formation of the 7. and mature HDL were tested as cholesterol acceptors (Fig. 4C) . As was the case of efflux to apoA-I, efflux from LXR-stimulated hepatocytes to rHDL as well as to human HDL 3 was similar in ABCG1+/+ and ABCG1-/-cells. Together, these data fail to show that ABCG1 contributes to cholesterol efflux from hepatocytes.
SR-BI, like ABCG1, is able to facilitate cholesterol efflux to HDL particles (19, 27). Fig. 1 ).
In line with cholesterol efflux to apoA-I, the formation of nascent HDL particles ranging in size from 7.4 to 14.0 nm in diameter was enhanced by LXR activation in both ABCG1+/+ and ABCG1-/-hepatocytes (Fig. 4E) . The lack of ABCG1 did not alter the particle levels or size compared with cells expressing ABCG1. Nascent HDL formation was inhibited by glyburide in a similar manner in ABCG1+/+ and ABCG1-/-cells, indicating that ABCG1 does not play a significant role in nascent HDL particle
formation. The accumulation of the 7.2 nm particle in the presence of glyburide was also similar for the two cell types, suggesting that its formation was also independent of ABCG1 expression.
Formation of nascent HDL in ABCA1-or ABCG1-overexpressing BHK cells
As another approach to assess the role of ABCA1 and ABCG1 in nascent HDL formation, BHK cells over-expressing ABCA1 or ABCG1 were studied. Significant amounts of ABCA1 or ABCG1 were expressed in mifepristone-treated ABCA1 or ABCG1 transfected BHK cells (Fig. 5A ). Similar to hepatocytes, a series of distinct nascent HDL particles were formed in BHK cells in an ABCA1-dependent manner and these nascent HDLs were of similar size to those produced by hepatocytes (Fig. 5B) . The over-expression of ABCG1 exerted only a minor stimulating effect on nascent HDL formation. Together, these results demonstrate that ABCA1 is sufficient for the observed (Fig. 6B) .
As in the case of cholesterol efflux, the formation of HDL particles was also increased in SR-BI-/-cells compared with that in SR-BI+/+ cells under basal conditions (Fig. 6C ),
suggesting that SR-BI may exert an inhibitory effect on nascent HDL particle formation.
The formation of nascent HDL particles ranging in size from 7.4 to 14.0 nm in diameter In the present study, glyburide, a non-selective ABC transporter inhibitor (40) was used to further examine the contribution of ABC transporters in HDL biogenesis. Cholesterol efflux to lipid-free apoA-I was markedly, but not completely inhibited by glyburide treatment under both basal and LXR-stimulated conditions. In the presence of glyburide, cholesterol efflux was greater in the T0901317-treated cells than in cells not treated with T0901317. As expected, glyburide treatment virtually abolished the formation of the major nascent HDLs in ABCA1+/+ hepatocytes. Most interestingly, a small novel lipidated apoA-I species (7.2 nm diameter) was identified whose pronounced accumulation was actually promoted by glyburide (Fig. 2C) . The production of a similarsized 7.2 nm particle has been reported by Krimbou et al. as a preβ 1 -migrating apoA-Icontaining particle produced by HepG2 cells and macrophages (15) . Based on the inhibitory effect of glyburide on ABCA1, the generation of these small particles in the presence of glyburide was considered to be independent of ABCA1. However, we showed that the 7.2 nm species was not detected in ABCA1-/-hepatocytes (Fig. 2C) ,
indicating that the formation of these particles is dependent on ABCA1. This is consistent with the observation that 7.2 nm particle formation was increased by LXR activation.
Whereas ABCA1 is required for the 7.2 nm particle production, ABCG1 and SR-BI did not affect this process.
Current models of the mechanism of ABCA1-dependent cholesterol efflux and nascent HDL formation (17, 43) , indicate that ABCA1-dependent apolipoprotein lipidation by guest, on November 9, 2017 www.jlr.org
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22 involves a multistep process that is initiated by the high-affinity binding of apoA-I or other apolipoproteins to ABCA1 in the plasma membrane (17) . Such binding stabilizes as well as activates ABCA1 phospholipid translocase activity (44). We suggest that the binding of apoA-I to ABCA1 is required to form the 7.2 nm particle. Earlier studies showed that apoA-I binding to ABCA1 in HEK cells was reduced in the presence of glyburide (40), although inhibition was only partial at the concentration used in our studies. Our results showed that glyburide treatment did not reduce the binding of apoA-I to ABCA1 in hepatocytes. Thus, binding of apoA-I to ABCA1 in the presence of glyburide may be sufficient to allow for limited apoA-I lipidation and the generation of the 7.2 nm particle through a process that is independent of ABCA1 functional activity.
Understanding the mechanism by which this novel particle is generated may provide new insight into the initial steps of apoA-I lipidation. It is possible that the 7. regulated by LXR. This confirms previous studies that in chow-fed mice the hepatocyte ABCG1 gene is expressed and highly up-regulated by LXR (24) or by a high cholesterol diet (22) . It has been reported that a lack of ABCG1 results in decreased plasma HDL cholesterol levels in mice fed a high cholesterol diet (22) . However, this remains controversial since other studies failed to demonstrate altered HDL levels in high fat fed ABCG1 deficient mice or in ABCG1 transgenic mice (23) (24) (25) . Our studies addressed the possibility that ABCG1 contributes to hepatic HDL biogenesis. Our findings, however, demonstrated that an absence of ABCG1 did not affect cholesterol efflux to apoA-I or nascent HDL particle formation, either under basal or LXR activated conditions. These results indicate that ABCG1 does not contribute to cholesterol efflux to apoA-I and nascent HDL formation, at least in hepatocytes.
Hepatic SR-BI plays a pivotal role in HDL cholesterol clearance from plasma and consequently plasma HDL cholesterol levels (48). SR-BI can also promote cellular cholesterol efflux to HDL (27) . However, SR-BI has been reported to inhibit ABCA1-mediated cholesterol efflux in macrophages (28) . In the present study we demonstrated that the absence of SR-BI did not inhibit nascent HDL particle formation or cholesterol efflux to apoA-I. To the contrary, cells lacking SR-BI showed enhanced capacity both to efflux cholesterol to apoA-I and to form nascent HDLs under basal conditions. This suggests that SR-BI may exert effects by mediating re-uptake of nascent HDLs or their lipid components from newly synthesized HDL particles. This is in line with the wellknown function of SR-BI in mediating selective lipid uptake from HDL particles. In contrast to our finding that SR-BI decreases cholesterol efflux to apoA-I, a recent study In summary, the present study demonstrates that the extent of cholesterol efflux to lipidpoor apoA-I is correlated with the formation of nascent HDL particles. A small novel 7.2 nm particle accumulates under conditions in which ABCA1 activity is inhibited. ABCA1
is required for generating nascent HDL particles, whereas ABCG1 does not affect nascent HDL particle formation. SR-BI does not promote but can rather decrease nascent HDL formation.
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